February 1, 2022 – Scottsdale – Hypersound Medical announced that it has filed with the United States Patent Office for a provisional patent for its groundbreaking microwave technology. The innovative technology is approaches pain management in a non-surgical, non-invasive, cost-effective way.

Since its incorporation in January of 2021, Hypersound Medical has focused its efforts on developing its unique non-invasive technology to alleviate pain. Chronic pain is a severe medical condition that affects millions of people globally, leading to a reduced quality of life and increased healthcare costs. Traditional pain management methods often involve addictive drugs, surgery, or other invasive procedures that can be risky and uncomfortable for patients. Hypersound Medical’s non-invasive device provides a safer and more effective way to manage pain without the use of addictive drugs.

The Hypersound device is designed to be portable, easy to use, and can be used in a variety of settings, including home, clinics, or hospitals. The microwave technology developed by Hypersound Medical is unlike any other in the market. It provides a safer and more effective way of managing pain, which is a significant improvement over traditional methods that often involve expensive invasive procedures or addictive drugs.

The decision by Hypersound Medical to file for a provisional patent is a strategic move aimed at protecting the revolutionary technology developed by the company.

Charles Jepson, the Chief Revenue and marketing Officer of Hypersound Medical, emphasized the innovative nature of the company’s technology and the importance of protecting it. The patent will give the company a competitive advantage and provide a significant boost to its overall growth strategy.

To learn more about the Hypersound technology, contact info@hypersoundmedical.com